Gilead Sciences Announces 4.4 Percent Increase in First Quarter 2021 Dividend
Gilead Sciences (Nasdaq: GILD) has announced a 4.4% increase in its quarterly cash dividend, raising it to $0.71 per share. This adjustment will take effect in the first quarter of 2021, with the dividend payable on March 30, 2021, to stockholders on record as of March 15, 2021. The decision reflects Gilead's ongoing commitment to returning value to shareholders, although future dividends will remain subject to approval by the Board of Directors.
- Dividend increase of 4.4% to $0.71 per share.
- Demonstrates commitment to shareholder value.
- None.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210204006013/en/
FAQ
What is the new dividend amount for Gilead Sciences?
When will the new dividend be paid?
What is the record date for the Gilead dividend?